2024-11-10 - Analysis Report
## Teladoc Health Inc. (TDOC) Stock Analysis Report

This report provides an in-depth analysis of Teladoc Health Inc. (TDOC) stock, considering various factors such as financial performance, market trends, and analyst opinions.

**1. Stock Performance and Valuation:**

* **TDOC** has experienced a cumulative return of 53.9% compared to the S&P 500's (VOO) cumulative return of 140.24%, resulting in a significant underperformance. The relative underperformance, as measured by the relative divergence, is currently at -86.34%, which indicates a substantial lag compared to the S&P 500.

* **Alpha and Beta Analysis:** TDOC has exhibited high volatility, with a Beta greater than 1 for most periods, indicating its price movements are more sensitive than the overall market. Its Alpha has been positive in the past, suggesting the potential for outperformance, but has declined significantly in recent years, reflecting the company's recent struggles.

**2. Recent Price Movement:**

* The current closing price for TDOC is 9.51 (last market: 9.23). 
* The stock is trading above its 5-day (9.24) and 20-day (9.16) moving averages, indicating potential short-term bullish sentiment. However, it is below its 60-day moving average (8.4), suggesting a longer-term bearish trend.

**3. Technical Indicators:**

* **RSI (Relative Strength Index):**  45.33 indicates neutral momentum.
* **PPO (Percentage Price Oscillator):** 0.12 suggests slight upward momentum.
* **Relative Divergence:**  The recent 20-day relative divergence is -1.04, implying a short-term downward trend.
* **Expected Return:**  The expected return for TDOC is currently at 0.0%, indicating a potential for long-term returns aligned with the S&P 500. However, it is important to note that this is a long-term outlook, and the stock may experience short-term volatility.

**4. Recent Earnings and Outlook:**

* TDOC has faced a challenging earnings environment in recent quarters, with consistent losses in earnings per share (EPS). 
* The latest reported EPS for the quarter ending 2024-10-31 was -0.19, significantly lower than the -0.35 expected. Revenue remains relatively stable but has shown a slight decline over the past few quarters. 

**5. Financial Data:**

* **Revenue and Profitability:**  TDOC has consistently generated strong revenue growth but continues to struggle with profitability. Despite a relatively high profit margin, the company has experienced losses in recent quarters.
* **Capital and Profitability:** TDOC's ROE has been negative in recent quarters, highlighting the company's challenges with generating returns on equity.  The significant decline in equity in the recent quarter is particularly concerning.

**6. News and Recent Issues:**

* The most recent earnings call highlighted the company's focus on cost reduction and streamlining operations. 
* Recent news reports suggest continued investor uncertainty regarding TDOC's future profitability and the long-term viability of its business model.
* Analyst opinions on TDOC have been largely negative, with a consensus “Hold” rating. 

**7. Overall Analysis:**

* TDOC is currently facing significant headwinds, with a weakening stock price, declining earnings, and concerns surrounding its long-term profitability. 
* While the company has a strong brand recognition in the telehealth space, its operational inefficiencies and persistent losses are raising questions about its future prospects.
* The stock's recent price movement suggests some short-term bullish sentiment, but the long-term trend remains bearish.
* Investors should carefully consider the risks associated with TDOC before making an investment decision.  

**Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. Always conduct thorough research and consult with a financial advisor before making any investment decisions.